Giacchetti, S. Et Al. 2016. Consistent dosing-time dependent tolerability of everolimus (EV) in a pilot study in women with metastatic breast cancers (MBC) and in a mouse chronopharmacology investigation.. San Antonio Breast Cancer Symposium 2016 (SABCS 2016) , (Teksas, United States Of America), 10.

Giacchetti, S., Li, X., ÖZTÜRK, N., Cuvier, C., Machowiak, J., Arrondeau, J., ... Chang-Marchand , Y.(2016). Consistent dosing-time dependent tolerability of everolimus (EV) in a pilot study in women with metastatic breast cancers (MBC) and in a mouse chronopharmacology investigation. . San Antonio Breast Cancer Symposium 2016 (SABCS 2016) (pp.10). Teksas, United States Of America

Giacchetti, Sylvie Et Al. "Consistent dosing-time dependent tolerability of everolimus (EV) in a pilot study in women with metastatic breast cancers (MBC) and in a mouse chronopharmacology investigation.," San Antonio Breast Cancer Symposium 2016 (SABCS 2016), Teksas, United States Of America, 2016

Giacchetti, Sylvie Et Al. "Consistent dosing-time dependent tolerability of everolimus (EV) in a pilot study in women with metastatic breast cancers (MBC) and in a mouse chronopharmacology investigation.." San Antonio Breast Cancer Symposium 2016 (SABCS 2016) , Teksas, United States Of America, pp.10, 2016

Giacchetti, S. Et Al. (2016) . "Consistent dosing-time dependent tolerability of everolimus (EV) in a pilot study in women with metastatic breast cancers (MBC) and in a mouse chronopharmacology investigation.." San Antonio Breast Cancer Symposium 2016 (SABCS 2016) , Teksas, United States Of America, p.10.

@conferencepaper{conferencepaper, author={Sylvie Giacchetti Et Al. }, title={Consistent dosing-time dependent tolerability of everolimus (EV) in a pilot study in women with metastatic breast cancers (MBC) and in a mouse chronopharmacology investigation.}, congress name={San Antonio Breast Cancer Symposium 2016 (SABCS 2016)}, city={Teksas}, country={United States Of America}, year={2016}, pages={10} }